Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention
Clinical trial NCT05338307 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05338307
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2027-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.